Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C

Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C

Lu-Hua Gao, Qing-He Nie, Xi-Tai Zhao Center of Infectious Diseases, Second Affiliated Hospital, Air-Force Military Medical University, Xi’an 710038, People’s Republic of ChinaCorrespondence: Qing-He NieCenter of Infectious Diseases, Second Affiliated Hospital, Air-Force Military...

Full description

Bibliographic Details
Main Authors:	Gao LH, Nie QH, Zhao XT
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-01-01
Series:	International Journal of General Medicine
Subjects:	drug-drug interaction direct-acting antiviral chronic hepatitis c pharmacokinetic comedication
Online Access:	https://www.dovepress.com/drugndashdrug-interactions-of-newly-approved-direct-acting-antiviral-a-peer-reviewed-article-IJGM

Similar Items

Role of different direct-acting antiviral drugs on hepatitis C virus-associated mixed cryoglobulinemia in Egyptian patients
by: Tarek A Elshazly, et al.
Published: (2019-01-01)

Detection of drug resistance mutations of hepatitis C virus in patients with failure of the treatment with direct acting antivirals
by: D. E. Valutite, et al.
Published: (2021-03-01)

The efficacy and safety of direct-acting antiviral drugs in the management of hepatitis C virus-related arthritis
by: Samah M. Alian, et al.
Published: (2020-09-01)

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
by: Po-Yao Hsu, et al.
Published: (2021-01-01)

A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments
by: Andrew Radley, et al.
Published: (2019-10-01)

Retrospective Evaluation on Patient Screening and Counseling Service on Direct-acting Antivirals Against Hepatitis C
by: Bob Ka Him Wong, et al.
Published: (2020-05-01)

Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs
by: Martynas Ridziauskas, et al.
Published: (2021-02-01)

Drug-drug interactions with direct-acting antivirals — less is more
by: Grace Lai-Hung Wong
Published: (2021-01-01)

New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01)

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
by: Emily L.C. Tan, et al.
Published: (2004-04-01)

Safety and efficacy of direct-acting antiviral drugs in the treatment of chronic hepatitis C virus infection in patients with thalassemia: a prospective study
by: Elsayed Ghoneem, et al.
Published: (2021-06-01)

Pharmacotherapy Profiles in People with Opioid Use Disorders: Considerations for Relevant Drug–Drug Interactions with Antiviral Treatments for Hepatitis C
by: Andreas Hintz, et al.
Published: (2021-05-01)

Limited drug–drug interaction of elbasvir/grazoprevir for chronic hepatitis C
by: Chun-Jen Liu, et al.
Published: (2020-05-01)

Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics
by: Chen R, et al.
Published: (2021-07-01)

Exploration of self-medication practice in Pokhara valley of Nepal
by: Sabita Paudel, et al.
Published: (2020-05-01)

Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance
by: Lize Cuypers, et al.
Published: (2015-09-01)

Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients
by: Curtis L. Cooper, et al.
Published: (2017-11-01)

Chronic Hepatitis C Treatment with New Antiviral Agents
by: Özlem KANDEMİR
Published: (2018-12-01)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
by: Asma Ahmed, et al.
Published: (2015-12-01)

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
by: Chung-Feng Huang, et al.
Published: (2020-07-01)

Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy
by: Nayana George, et al.
Published: (2018-01-01)

Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
by: Nicola Imperatore, et al.
Published: (2017-11-01)

Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era
by: Andrew A. Li, et al.
Published: (2018-07-01)

Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India
by: Varun Gupta, et al.
Published: (2017-01-01)

Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis
by: Christiana Graf, et al.
Published: (2020-08-01)

Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients
by: Asmaa M. Elbrolosy, et al.
Published: (2021-03-01)

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
by: Hassan AM, et al.
Published: (2018-06-01)

Molecular Characterization of Hepatitis C Virus for Developed Antiviral Agents Resistance Mutations and New Insights into in-silico Prediction Studies
by: El-Sokkary MMA, et al.
Published: (2020-11-01)

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
by: Stelliana Goutzamanis, et al.
Published: (2021-07-01)

Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C
by: Fátima Falcão, et al.
Published: (2019-03-01)

Identification and Tracking of Antiviral Drug Combinations
by: Aleksandr Ianevski, et al.
Published: (2020-10-01)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
by: Elfi Egmond, et al.

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case Report
by: Elise J. Smolders, et al.
Published: (2018-05-01)

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
by: Soon Young Ko, et al.
Published: (2018-12-01)

Topical problems of antiviral therapy for chronic hepatitis C
by: I G Bakulin
Published: (2015-11-01)

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
by: Mohamed M Sakr, et al.
Published: (2019-01-01)

Emerging resistance to directly-acting antiviral therapy in treatment of chronic Hepatitis C infection—A brief review of literature
by: Mohit Bhatia, et al.
Published: (2020-01-01)

Mechanisms and the clinical relevance of complex drug–drug interactions
by: Roberts AG, et al.
Published: (2018-09-01)

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
by: Claudia Westermann, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_ao2hr755dl2ial1ksla54urb5f